CREDOPHAR
0849.730.193 · rovalta.com · 22/09/2026
CREDOPHAR
Overview
What does CREDOPHAR do?
CREDOPHAR is a Private limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.
9051 Gent · FlandreSee on map
Joint committees (2)
- 100
- 200
Trend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Gross margin | 257,7 k € | +134% | 110 k € | -78.6% | 514,4 k € | -53.7% | 1,1 M € | -18.7% | 1,4 M € | +6.6% | 1,3 M € | +6.8% | 1,2 M € | +10.2% | 1,1 M € | +11.1% | 980,1 k € | +176% | 355,1 k € | -40.7% | 598,9 k € | +72.2% | 347,8 k € | +181% | 123,9 k € |
| EBITDA | 255,1 k € | +263% | 70,2 k € | -86.2% | 507,5 k € | -13.1% | 583,8 k € | -38.6% | 951,1 k € | +41.8% | 670,8 k € | +21.7% | 551,1 k € | +2.3% | 538,5 k € | +10.7% | 486,4 k € | +252% | 138,3 k € | -24.4% | 183 k € | +251% | 52,1 k € | +152% | -101 k € |
| Operating result | 275,1 k € | +302% | 68,4 k € | -86.0% | 487,5 k € | -15.3% | 575,5 k € | -39.5% | 951,1 k € | +62.9% | 584 k € | +27.2% | 459,3 k € | +5.8% | 434 k € | +15.2% | 376,7 k € | +362% | 81,5 k € | +39.3% | 58,5 k € | +37.5% | 42,6 k € | +140% | -107,4 k € |
| Net result | 51,7 k € | +128% | -182,3 k € | -191% | 200,7 k € | -37.3% | 320,2 k € | -53.4% | 686,9 k € | +103% | 338,4 k € | +30.3% | 259,7 k € | +0.4% | 258,6 k € | +28.0% | 202,1 k € | +472% | 35,3 k € | +234% | 10,6 k € | -34.2% | 16,1 k € | +115% | -110,3 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | 1,9 M € | +2.8% | 1,9 M € | -8.8% | 2,1 M € | +10.8% | 1,9 M € | +20.8% | 1,5 M € | +48.8% | 1 M € | +48.6% | 697 k € | +59.4% | 437,3 k € | +145% | 178,7 k € | +865% | -23,4 k € | +60.2% | -58,7 k € | +15.3% | -69,3 k € | +18.9% | -85,4 k € |
| Total assets | 7,8 M € | +2.6% | 7,6 M € | +0.1% | 7,6 M € | -10.3% | 8,5 M € | +320% | 2 M € | -28.7% | 2,8 M € | +22.6% | 2,3 M € | +3.4% | 2,2 M € | -17.8% | 2,7 M € | +44.3% | 1,9 M € | +4.8% | 1,8 M € | +551% | 276,5 k € | +85.4% | 149,1 k € |
| Cash | – | – | – | 1,1 M € | -10.1% | 1,2 M € | +61.3% | 749,2 k € | +416% | 145 k € | +2.6% | 141,4 k € | -54.7% | 312,4 k € | +111% | 148,1 k € | +124% | 66,2 k € | +284% | 17,2 k € | – | ||||
| Debts | 5,4 M € | -1.1% | 5,5 M € | +3.6% | 5,3 M € | -19.4% | 6,6 M € | +1264% | 483,7 k € | -73.2% | 1,8 M € | +11.5% | 1,6 M € | -10.2% | 1,8 M € | -29.2% | 2,5 M € | +33.2% | 1,9 M € | +8.2% | 1,8 M € | +411% | 345,8 k € | +47.5% | 234,5 k € |
| Other | |||||||||||||||||||||||||
| Workforce | – | – | – | 4,7 ETP | -31.9% | 6,9 ETP | -33.0% | 10,3 ETP | -8.8% | 11,3 ETP | +14.1% | 9,9 ETP | -7.5% | 10,7 ETP | +1.9% | 10,5 ETP | +26.5% | 8,3 ETP | +12.2% | 7,4 ETP | +85.0% | 4,0 ETP | |||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
b+pharma Belgium● Active | 0474.817.869 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
Ceres Pharmaceuticals● Active | 0407.326.754 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
DGPharma● Active | 0508.925.544 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
KOUTERLOS● Active | 0450.036.349 |
Labophar● Active | 0643.723.177 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/08/2026 | 30/07/2025 | 25/07/2024 | 29/08/2023 | 25/08/2022 | 03/03/2021 |
| General meeting | 15/06/2026 | 30/06/2025 | 30/06/2024 | 29/08/2023 | 15/07/2022 | 19/02/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
13 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 15/06/2026 | 26/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 30/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/06/2024 | 25/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 29/08/2023 | 29/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 15/07/2022 | 25/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 19/02/2021 | 03/03/2021 | Dutch | |
| Abridged model | 31/12/2019 | 15/06/2020 | 01/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 17/06/2019 | 02/09/2019 | Dutch | |
| Abridged model | 31/12/2017 | 29/01/2018 | 05/02/2018 | Dutch | |
| Abridged model | 31/12/2016 | 19/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 30/06/2016 | 01/12/2016 | 26/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 03/12/2015 | 04/02/2016 | Dutch | |
| Abridged model | 30/06/2014 | 04/12/2014 | 12/01/2015 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates03/09/2024ONTSLAGEN - BENOEMINGEN
- Mandates16/12/2022MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Other08/11/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates17/05/2021ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
- Restructuring12/05/2021KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring23/02/2021KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Other31/01/2017DOEL - ALGEMENE VERGADERING - BOEKJAAR
- Registered office13/05/2016MAATSCHAPPELIJKE ZETEL
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202551,7 k €↑
- 2024Annual accounts 2024-182,3 k €↓
- 2023Annual accounts 2023200,7 k €↓
- 2022Annual accounts 2022320,2 k €↓
- 2021Annual accounts 2021686,9 k €↑
- 2020Annual accounts 2020338,4 k €↑
- 2019Annual accounts 2019259,7 k €↑
- 2018Annual accounts 2018258,6 k €↑
- 2017Annual accounts 2017202,1 k €↑
- 2016Annual accounts 201635,3 k €↑
- 2016Annual accounts 201610,6 k €↓
- 2015Annual accounts 201516,1 k €↑
- 2014Annual accounts 2014-110,3 k €
- 16/10/2012IncorporationPrivate limited company